Hangzhou Haishan Pharmaceutical Equipment Co., Ltd. announced a private placement of common shares at the price of CNY 1.51 per share for gross proceeds of CNY 20 million on July 18, 2022. The transaction will include participation from new investor Zhejiang Wecome Pharmaceutical Company Limited for an equity stake of 70%. The transaction has been approved at the seventh meeting of the third board of directors of Zhejiang Wecome Pharmaceutical Company Limited.

The company will include CNY 13.2741 million in the paid-in capital, and CNY 6.7259 million in the capital reverse.